Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
FundPlus is a private foundation founded in May 2015 by Désiré Collen and Life Sciences Research Partners, based in Leuven, Belgium. The firm has raised €200 million in financing commitments and operates as a Belgian Naamloze Vennootschap/Société Anonyme (NV/SA). FundPlus focuses on long-term equity investments in life sciences companies, aiming to create sustainable shareholder value and contribute positively to society.
FundPlus invests in innovative life sciences companies, particularly in therapeutics, diagnostics, and medical devices. The firm targets Series A and B financing for companies that have achieved proof of concept, with investment sizes ranging from €5 million to €15 million. FundPlus seeks to hold significant minority stakes (over 10%) and actively participates as board members in its portfolio companies.
Notable portfolio companies include Minoryx, a clinical-stage biotech developing therapies for orphan CNS diseases; AstriVax Therapeutics, focused on a Plug & Play vaccine platform; Coave Therapeutics, which develops gene therapies for rare retinal diseases; Immunic Therapeutics, specializing in oral immunology therapies; eTheRNA Immunotherapies, applying mRNA for cancer treatment; Novadip Biosciences, working on critical tissue reconstruction; and Cellaïon, focused on liver failure treatments.
Email info@fundplus.be with your deck to pitch FundPlus.
Yes, FundPlus typically leads investment rounds, particularly in Series A and B financing stages.
FundPlus is open to follow-on investments, especially if the portfolio company meets its milestones and demonstrates growth potential.
FundPlus has a total fund size of €200 million, which it utilizes for investments in life sciences companies across Europe.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.